GLTO - Bathi sadurunge bunga, pajak, lan amortisasi Galecto Inc
Galecto, Inc. (GLTO) struggle to regain shareholder confidence following failed trials is evidenced by volatility: changes in EBITDA_Co demonstrate high sensitivity to shocks, where the current parameter equals 0.00. Stability is provided by multi-billion dollar investments in R&D for galectin inhibitors. These developments aim to curb tissue scarring in the liver and lungs, preventing irreversible organ degradation.
Ringkesan rincian data analitis Galecto (GLTO)
- kuotasi saiki lan rata-rata prakiraan nilai:
- statistik kapitalisasi pasar:
- data kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Galecto, Inc.|GLTO - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Galecto Inc|GLTO - Utang perusahaan|Rasio utang marang kapitalisasi buku Galecto|GLTO - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Galecto|Koefisien jangkoan perantara galecto.com
- rincian asil keuangan lan kelipatan valuasi:
GLTO - Bathi resik perusahaan|Bathi mangsa ngarep Galecto, Inc.|GLTO - Pangali P/E|Pangali forward rega marang bathi galecto.com|GLTO - Pangali PEG|Pangali EV/EBITDA Galecto|GLTO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Galecto|GLTO - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan galecto.com|GLTO - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Galecto, Inc.
Analisis kabeh metrik perusahaan:Galecto Corporation (GLTO)
For Galecto, Inc., which is developing a diversified portfolio of anti-fibrotic drugs, the scale of operations is determined by the ability to fund multi-profile research. This metric measures net cash flow from operating activities before interest and taxes, allowing the investor to strip away accounting adjustments and assess the real solvency of the business through the history of operating profit in cash.
Karo sapa Galecto, Inc. saingan
ASND - Bathi operasional sadurunge ngurangi amortisasi|Madrigal Pharmaceuticals - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi corcept.com|RYTM (Rhythm Pharmaceuticals, Inc.) - Bathi operasional sadurunge ngurangi amortisasi|AKRO: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|MTSR (Metsera Corp) - Bathi operasional EBITDA|Bathi operasional EBITDA MoonLake Corp|Bathi operasional EBITDA CRNX|Bathi sadurunge mbayar bunga, pajak, lan amortisasi NAMS (newamsterdampharma.com)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Soleno Therapeutics, Inc. SLNO|Amicus Therapeutics Inc (FOLD) - Bathi sadurunge bunga, pajak, lan amortisasi|ETNB - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|AGIO: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|GPCR: Bathi operasional EBITDA|MDXG - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Rezolute|Lexicon Pharmaceuticals Inc (LXRX) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi MBX Bio (MBX)|Bathi operasional sadurunge ngurangi amortisasi Altimmune Pharma ALT|Bathi operasional EBITDA AARD (Aardvark Therapeutics Inc)|Bathi operasional sadurunge potongan amortisasi sagimet.com|BioAge - Bathi operasional EBITDA|BMEA - Bathi operasional EBITDA|quincetx.com (QNCX) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|GUTS (Fractyl Health, Inc) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|VTVT (vTv Therapeutics, Inc.) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Agape ATP Corp. ATPC|Bathi operasional EBITDA PLUR|Bathi operasional sadurunge ngurangi amortisasi synlogictx.com SYBX|Lipocine Corp - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi MTNB (Matinas BioPharma Holdings, Inc.)|SPRB - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi carmellrx.com|LUMO (Lumos Pharma) - Bathi operasional sadurunge ngurangi amortisasi|Organovo Holdings - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|RDUS (Radius Health) - Bathi operasional EBITDA
